BILL NUMBER: AB 1073 INTRODUCED
BILL TEXT
INTRODUCED BY Assembly Member Ting
FEBRUARY 27, 2015
An act to amend Section 4076.5 of the Business and Professions
Code, relating to pharmacy.
LEGISLATIVE COUNSEL'S DIGEST
AB 1073, as introduced, Ting. Pharmacy: prescription drug labels.
The Pharmacy Law provides for the licensure and regulation of
pharmacists by the California State Board of Pharmacy. That law
requires the board to promulgate regulations that require, on or
before January 1, 2011, a standardized, patient-centered,
prescription drug label on all prescription medicine dispensed to
patients in California. Existing regulations of the board implement
that requirement.
This bill would remove that obsolete date.
Vote: majority. Appropriation: no. Fiscal committee: no.
State-mandated local program: no.
THE PEOPLE OF THE STATE OF CALIFORNIA DO ENACT AS FOLLOWS:
SECTION 1. Section 4076.5 of the Business and Professions Code is
amended to read:
4076.5. (a) The board shall promulgate regulations that
require, on or before January 1, 2011, require a
standardized, patient-centered, prescription drug label on all
prescription medicine dispensed to patients in California.
(b) To ensure maximum public comment, the board shall hold public
meetings statewide that are separate from its normally scheduled
hearings in order to seek information from groups representing
consumers, seniors, pharmacists or the practice of pharmacy, other
health care professionals, and other interested parties.
(c) When developing the requirements for prescription drug labels,
the board shall consider all of the following factors:
(1) Medical literacy research that points to increased
understandability of labels.
(2) Improved directions for use.
(3) Improved font types and sizes.
(4) Placement of information that is patient-centered.
(5) The needs of patients with limited English proficiency.
(6) The needs of senior citizens.
(7) Technology requirements necessary to implement the standards.
(d) The board may exempt from the requirements of
regulations promulgated pursuant to subdivision (a)
prescriptions dispensed to a patient in a health facility, as defined
in Section 1250 of the Health and Safety Code, if the prescriptions
are administered by a licensed health care professional.
Prescriptions dispensed to a patient in a health facility that will
not be administered by a licensed health care professional or that
are provided to the patient upon discharge from the facility shall be
subject to the requirements of this section and
the regulations promulgated pursuant to subdivision (a). Nothing in
this subdivision shall alter or diminish existing statutory and
regulatory informed consent, patients' rights, or pharmaceutical
labeling and storage requirements, including, but not limited to,
the requirements of Section 1418.9 of the Health
and Safety Code or Section 72357, 72527, or 72528 of Title 22 of the
California Code of Regulations.
(e) (1) The board may exempt from the requirements of
regulations promulgated pursuant to subdivision (a) a
prescription dispensed to a patient if all of the following apply:
(A) The drugs are dispensed by a JCAHO-accredited home infusion or
specialty pharmacy.
(B) The patient receives health-professional-directed education
prior to before the beginning of
therapy by a nurse or pharmacist.
(C) The patient receives weekly or more frequent followup contacts
by a nurse or pharmacist.
(D) Care is provided under a formal plan of care based upon a
physician and surgeon's orders.
(2) For purposes of paragraph (1), home infusion and specialty
therapies include parenteral therapy or other forms of administration
that require regular laboratory and patient monitoring.